biotech · Neonatal Infections · Locally Advanced / Metastatic Solid Tumors · CBIO
CRESCENT BIOPHARMA
CRESCENT BIOPHARMA, INC.
CRESCENT BIOPHARMA clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Waltham, USA HQ
57 Employees
Public company Type
CBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Employees
- 57
- Programs
- 3
- Drugs
- 5
- Patents
- 2
CRESCENT BIOPHARMA projects
3 ClinicalTrials.gov programs sponsored by CRESCENT BIOPHARMA.
CRESCENT BIOPHARMA has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does CRESCENT BIOPHARMA have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.